NCT03095196View on ClinicalTrials.gov

Multipolar CRT-d and Diabetes

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

September 1, 2012

Primary Completion Date

September 1, 2014

Study Completion Date

September 1, 2015

Conditions
DiabetesHeart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III
Interventions
DEVICE

Multipolar CRT-d, plus conventional drug therapy for HF.

A random CRT-d implant performed via multipolar left ventricle lead, in failing heart patients treated by maximal drug therapy.

DEVICE

Bipolar CRT-d, plus conventional drug therapy for HF.

A random CRT-d implant performed via bipolar left ventricle lead (group B), in failing heart patients treated by maximal drug therapy.

DRUG

HF drugs

full medical therapy to treat HF symptoms and its progression.

All Listed Sponsors
lead

Celestino Sardu

OTHER

NCT03095196 - Multipolar CRT-d and Diabetes | Biotech Hunter | Biotech Hunter